Lifastuzumab (Anti-SLC34A2)
Lifastuzumab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. MW : 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2350 |
Sku # | A2350-1mg*5 |
Pricing | 1mg*5, $1690.00 |